Vumedi's AI Search Taps 100,000 Physician Videos for Peer-to-Peer Learning

The 15-year-old platform, fresh off a $104 million Series B, is using its deep library of specialist videos to power a new wave of clinical AI search.

About Vumedi

Published

For a physician facing a complex case, the most valuable resource is often not a textbook or a vendor-sponsored course, but the experience of a colleague who has seen it before. Vumedi, a 15-year-old Oakland-based company, has spent over a decade building a digital library of that experience, amassing more than 100,000 physician-led videos and nearly 5,000 podcast episodes across 21 specialties [Oak HC/FT, November 2026]. Now, with a recent $104 million Series B from healthcare-focused investor Oak HC/FT, it is betting that its archive of peer knowledge can become the foundation for a new kind of clinical AI [Business Wire, November 2026]. The goal is not to replace the doctor, but to connect them faster to the nuanced, practical expertise of other practicing clinicians.

The peer-learning wedge

Vumedi’s core bet is that clinical education works best when it bypasses traditional, often generic, continuing medical education (CME) in favor of direct peer-to-peer learning. The platform’s content comes from specialists at leading institutions like the Cleveland Clinic, Mayo Clinic, and Stanford, covering everything from surgical techniques to rare disease management [Signalbase, retrieved 2026]. This creates a library of practical, case-based knowledge that is inherently more relevant to daily practice. The company reports that more than 500,000 healthcare professionals now use the platform, spending over 4.3 million minutes per month learning on it [Vumedi, retrieved 2026] [Oak HC/FT, November 2026]. This massive, engaged user base and its contributed content form a data moat that is difficult for newcomers to replicate quickly.

Why Oak HC/FT wrote a nine-figure check

The $104 million investment, led by Oak HC/FT in November 2026, represents a significant validation of Vumedi’s transition from a content library to an AI-powered learning engine [Oak HC/FT, November 2026]. The capital is earmarked for talent acquisition, research and development, and product expansion [CFO Tech, November 2026]. For the investor, the appeal likely lies in Vumedi’s unique position: it owns a proprietary, clinician-created dataset and has an existing, trusted relationship with a vast network of doctors. This allows its AI tools to be built directly into a clinician’s established workflow, rather than being introduced as a standalone, disruptive product. The early traction for these AI features has been strong, with the company reporting they were used by more than 150,000 NPI-verified clinicians and generated over one million interactions within their first year [Business Wire, November 2026].

The team scaling a medical community

Founder and CEO Roman Giverts has led Vumedi since its inception in 2008, a remarkably long runway for a venture-backed healthtech company [Vumedi, retrieved 2026]. A key figure in scaling its educational reach is Chief Education Officer Desirae Hazen, who joined as the tenth employee and built its cardiovascular community before expanding the education team to cover 25 medical specialties [Perplexity Sonar Pro Brief, retrieved 2026]. This focus on deep, specialty-specific community building, rather than just content aggregation, has been central to the platform's credibility. The company now has an estimated 250 employees distributed across 39 locations, with clusters in Minneapolis, Oakland, and San Francisco [Datanyze, retrieved 2026] [Unify, retrieved 2026].

Role Name Key Detail
Founder & CEO Roman Giverts Has led the company since its 2008 founding.
Chief Education Officer Desirae Hazen Joined as tenth employee; scaled education to 25 specialties.
Chief People Officer Evan Wittenberg Leadership role confirmed in public sources.
Director of Engineering Ivan Šimičić Engineering leadership confirmed on LinkedIn.

Navigating a crowded and cautious market

While Vumedi’s library and user base are formidable, the market for digital clinical education and decision support is both crowded and highly regulated. The company’s success hinges on several factors that carry inherent risk. Its AI tools, while promising, are new and their impact on clinical outcomes has not yet been validated through peer-reviewed study. Furthermore, the platform’s business model appears to be a blend of enterprise partnerships and individual clinician access, but specific pricing and the exact nature of its revenue streams are not detailed in public filings. Finally, clinician time is a fiercely contested resource, with countless platforms vying for attention alongside mandatory institutional training.

Vumedi’s most plausible answer to these challenges is its foundational focus on peer-created content. By ensuring its AI search surfaces answers from verified specialists within its own network, it aims to maintain a level of trust and relevance that generic large language models or vendor-produced materials cannot match. The company is not asking doctors to trust a black box, but to use a tool that efficiently connects them to colleagues they might otherwise never meet.

The next twelve months

The immediate roadmap, fueled by the Series B, will focus on deepening the AI product and expanding its reach. Key milestones to watch will be the publication of any data on how the AI tools influence clinical decision-making or patient outcomes, a critical step for broader adoption. Strategic partnerships with major hospital systems to embed Vumedi’s learning modules into their internal training platforms could also be a logical next step, leveraging its existing relationships with top-tier institutions.

For the hundreds of thousands of clinicians using Vumedi, the platform addresses a very specific need: the gap between formal education and the practical, often unspoken, knowledge gained from experience. In specialties from orthopedics to rheumatology, where techniques and treatments evolve rapidly, having immediate access to how a leading specialist at Mayo Clinic approaches a problem can directly inform patient care [Vumedi, retrieved 2026]. The standard of care today often involves sifting through journals, attending conferences, or relying on informal networks. Vumedi’s bet is that a searchable, video-based repository of peer expertise, augmented by AI, can make that process more efficient and ultimately improve the quality of care delivered at the bedside.

Sources

  1. [Vumedi, retrieved 2026] Vumedi company website | https://www.vumedi.com/
  2. [Oak HC/FT, November 2026] Vumedi: Connecting Physicians to the Expertise that Advances Care | https://www.oakhcft.com/blog-post/vumedi-connecting-physicians-to-the-expertise-that-advances-care
  3. [Business Wire, November 2026] Vumedi Expands AI-Powered Physician Learning as Medical Innovation Accelerates | https://www.businesswire.com/news/home/20261110245713/en/Vumedi-Expands-AI-Powered-Physician-Learning-as-Medical-Innovation-Accelerates
  4. [CFO Tech, November 2026] Vumedi expands AI learning tools after USD $104m funding | https://cfotech.news/story/vumedi-expands-ai-learning-tools-after-usd-104m-funding
  5. [Perplexity Sonar Pro Brief, retrieved 2026] Web-grounded research brief on Vumedi
  6. [Signalbase, retrieved 2026] Signalbase company profile data
  7. [Datanyze, retrieved 2026] Datanyze company profile data
  8. [Unify, retrieved 2026] Unify company location data
  9. [LinkedIn, retrieved 2026] Professional profiles for Ivan Šimičić and Desirae Hazen

Read on Startuply.vc